-
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
19 Dec 2025 13:49 GMT
… -drug conjugate being tested for lung cancer, a spokesperson for the companies … patients with relapsed small cell lung cancer. Participants were treated with I … an active chemotherapy comparator, including topotecan, amrubicin and lurbinectedin.
In a …
-
<![CDATA[FDA Grants Full Approval to Tarlatamab in Small Cell Lung Cancer]]>
20 Nov 2025 10:47 GMT
… with extensive stage small cell lung cancer (ES-SCLC) with … aggressive nature, small cell lung cancer has long been particularly … of lurbinectedin (n = 47), topotecan (n = 185), or amrubicin … for extensive-stage small-cell lung cancer. FDA. November 19, 2025 …
-
<![CDATA[FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer]]>
20 Nov 2025 05:20 GMT
… Chemotherapy in Relapsed Small Cell Lung Cancer (DeLLphi-304)
ClinicalTrials.gov … standard of care chemotherapy—either topotecan, lurbinectedin, or amrubicin—(n = … Chemotherapy in Relapsed Small Cell Lung Cancer (DeLLphi-304). ClinicalTrials.gov …
-
<![CDATA[FDA Grants Full Approval to Tarlatamab for Extensive-Stage Small Cell Lung Cancer]]>
20 Nov 2025 04:24 GMT
… (Zepzelca; n = 47), topotecan (n = 185), or amrubicin … ), and intended chemotherapy (topotecan/amrubicin vs lurbinectedin … extensive stage small cell lung cancer. FDA. November 19, … Tarlatamab in small-cell lung cancer after platinum-based chemotherapy …
-
<![CDATA[FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer]]>
19 Nov 2025 22:07 GMT
… with extensive-stage small cell lung cancer (ES-SCLC) with disease progression … included patients with small cell lung cancer whose disease had grown after … standard chemotherapy, which could be topotecan, lurbinectedin or amrubicin. Patients stayed …
-
FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer
19 Nov 2025 20:04 GMT
… with extensive stage small cell lung cancer (ES-SCLC) with disease progression … standard of care (SOC) chemotherapy (topotecan, lurbinectedin, or amrubicin) until disease …
-
Oxygenation: Nanotechnological Strategies for Conquering Tumor Hypoxia in Photodynamic Therapy
09 Feb 2026 17:47 GMT
… HIF-1α, such as acriflavine, topotecan and capsaicin.39,69 Lv … in advanced non-small cell lung cancer: a review of the … cancer or non-small-cell lung cancer (consolidative use of radiotherapy to … management of non-small cell lung cancer in a central/ …
-
<![CDATA[DLL3 Emerges as an Actionable Target in Small Cell Lung Cancer]]>
27 Sep 2025 13:14 GMT
… lurbinectedin (n = 47), topotecan (n = 185), or amrubicin … previously treated small cell lung cancer receiving tarlatamab: results … treatment for small cell lung cancer (SCLC): primary analysis … Tarlatamab in small-cell lung cancer after platinum-based …
-
<![CDATA[Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial]]>
11 Sep 2025 17:43 GMT
… cell lung cancer is the most aggressive type of lung cancer with … with either paclitaxel or topotecan for patients in the … than non-small cell lung cancer. Lung cancer is the second most … Patients With Small-cell Lung Cancer in Combination With Chemotherapy. …
-
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
08 Sep 2025 15:00 GMT
… Lung Cancer in Barcelona. “Small cell lung cancer is the most aggressive type of lung cancer … -stage small cell lung cancer (Cohort 1) … plus paclitaxel, or topotecan in the second- … Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancer …
About
© 1995-2026